| Literature DB >> 25243143 |
Mingzhi Liao1, Yingbo Miao2, Liangcai Zhang3, Yang Wang1, Rennan Feng4, Lei Yang5, Shihua Zhang6, Yongshuai Jiang5, Guiyou Liu7.
Abstract
Liuwei-dihuang (LWDH) is widely used in traditional Chinese medicine (TCM), but its molecular mechanism about gene interactions is unclear. LWDH genes were extracted from the existing literatures based on text mining technology. To simulate the complex molecular interactions that occur in the whole body, protein-protein interaction networks (PPINs) were constructed and the topological properties of LWDH genes were analyzed. LWDH genes have higher centrality properties and may play important roles in the complex biological network environment. It was also found that the distances within LWDH genes are smaller than expected, which means that the communication of LWDH genes during the biological process is rapid and effectual. At last, a comprehensive network of LWDH genes, including the related drugs and regulatory pathways at both the transcriptional and posttranscriptional levels, was constructed and analyzed. The biological network analysis strategy used in this study may be helpful for the understanding of molecular mechanism of TCM.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25243143 PMCID: PMC4163428 DOI: 10.1155/2014/484926
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Topological definition used in the study.
| Name | Definition | Description |
|---|---|---|
| ASP |
|
|
|
| ||
| Betweenness |
|
|
|
| ||
| Closeness |
|
|
|
| ||
| Clustering coefficient |
|
|
|
| ||
| Degree |
| The number of links to node |
|
| ||
| Eccentricity |
| The maximum node eccentricity ( |
|
| ||
| Radiality |
| This attribute is a node centrality index computed by the diameter ( |
|
| ||
| Stress |
|
|
|
| ||
| Topological coefficient |
|
|
Figure 1Workflow diagram of our approach to construct comprehensive biological network about LWDH genes. The left frame represents the component of LWDH. After the mining of related genes of LWDH based on natural language technology in PubMed, comprehensive information was obtained, including protein-protein interaction, transcription regulation, drug-drug interaction, and drug-target interaction (middle frame). At last, the comprehensive network of LWDH genes was constructed (right frame).
Functional enrichment analysis of LWDH genes in the biological process branch of GO.
| GOID | Term | Count | Count% |
| FDR |
|---|---|---|---|---|---|
| GO:0043066 | Negative regulation of apoptosis | 18 | 18.9 | 4.00 | 6.80 |
| GO:0043069 | Negative regulation of programmed cell death | 18 | 18.9 | 5.00 | 8.50 |
| GO:0060548 | Negative regulation of cell death | 18 | 18.9 | 5.30 | 8.90 |
| GO:0042981 | Regulation of apoptosis | 23 | 24.2 | 1.10 | 1.90 |
| GO:0043067 | Regulation of programmed cell death | 23 | 24.2 | 1.40 | 2.30 |
| GO:0010941 | Regulation of cell death | 23 | 24.2 | 1.50 | 2.50 |
| GO:0010033 | Response to organic substance | 20 | 21.1 | 5.30 | 9.00 |
| GO:0006916 | Antiapoptosis | 12 | 12.6 | 1.20 | 2.10 |
| GO:0042127 | Regulation of cell proliferation | 20 | 21.1 | 2.20 | 3.70 |
| GO:0009719 | Response to endogenous stimulus | 15 | 15.8 | 2.70 | 4.70 |
| GO:0070482 | Response to oxygen levels | 10 | 10.5 | 6.20 | 1.10 |
| GO:0009725 | Response to hormone stimulus | 14 | 14.7 | 6.90 | 1.20 |
| GO:0043065 | Positive regulation of apoptosis | 14 | 14.7 | 4.30 | 7.30 |
| GO:0043068 | Positive regulation of programmed cell death | 14 | 14.7 | 4.60 | 7.90 |
| GO:0010942 | Positive regulation of cell death | 14 | 14.7 | 4.90 | 8.30 |
| GO:0001666 | Response to hypoxia | 9 | 9.5 | 5.90 | 1.00 |
| GO:0048545 | Response to steroid hormone stimulus | 10 | 10.5 | 8.60 | 1.50 |
| GO:0001776 | Leukocyte homeostasis | 6 | 6.3 | 1.30 | 2.20 |
| GO:0042592 | Homeostatic process | 17 | 17.9 | 1.90 | 3.20 |
| GO:0006915 | Apoptosis | 15 | 15.8 | 3.30 | 5.70 |
| GO:0051384 | Response to glucocorticoid stimulus | 7 | 7.4 | 3.80 | 6.40 |
| GO:0012501 | Programmed cell death | 15 | 15.8 | 4.00 | 6.70 |
| GO:0043029 | T cell homeostasis | 5 | 5.3 | 4.40 | 7.40 |
| GO:0045884 | Regulation of survival gene product expression | 5 | 5.3 | 4.40 | 7.40 |
| GO:0008219 | Cell death | 16 | 16.8 | 5.40 | 9.10 |
| GO:0016265 | Death | 16 | 16.8 | 5.80 | 9.90 |
Figure 2Subnetwork of LWDH genes from BioGrid and HPRD.
Centrality analysis of LWDH genes in BioGrid.
| Measurements | LWDH | Other |
|
−log10( |
|---|---|---|---|---|
| ASP | 3.322458 | 3.756768 | 7.13 | 11.14671 |
| Betweenness | 0.002336 | 0.000242 | 1.49 | 10.82709 |
| Closeness | 0.308365 | 0.27118 | 7.01 | 17.15445 |
| Clustering coefficient | 0.113448 | 0.156074 | 0.155779 | 0.807491 |
| Degree | 46.88732 | 9.596803 | 1.64 | 30.78599 |
| Eccentricity | 7.309859 | 7.731794 | 2.9 | 7.537242 |
| Radiality | 0.788867 | 0.749385 | 7.13 | 11.14671 |
| Stress | 5075568 | 500694.1 | 1.36 | 15.86601 |
| Topological coefficient | 0.129467 | 0.178003 | 0.032223 | 1.491832 |
Centrality analysis of LWDH genes in HPRD.
| Measurements | LWDH | Other |
| −log10( |
|---|---|---|---|---|
| ASP | 3.773832 | 4.229902 | 4.34 | 9.362655 |
| Betweenness | 0.002235 | 0.000337 | 2.59 | 24.58708 |
| Closeness | 0.270647 | 0.240556 | 3.86 | 14.4135 |
| Clustering coefficient | 0.061171 | 0.10591 | 0.088168 | 1.054689 |
| Degree | 30.52308 | 7.82407 | 8.74 | 35.05851 |
| Eccentricity | 9.323077 | 9.803829 | 9.55 | 7.019855 |
| Radiality | 0.801869 | 0.769293 | 4.34 | 9.362655 |
| Stress | 2551317 | 349608.7 | 1.47 | 28.83402 |
| Topological coefficient | 0.103758 | 0.201088 | 3.1 | 4.508613 |
Figure 3Comparison of the shortest path length between pairs of LWDH genes and pairs of other nodes. The left groups represent pairs of genes that are related to LWDH, and the right groups represent pairs of genes that are not related to LWDH. The measurement of SPL means the shortest path length of gene pairs in each group.
Figure 4Comprehensive network of LWDH genes. Green represents drugs; purple represents LWDH genes; blue represents TFs; cyan represents miRNAs.
Diseases related to LWDH genes in OMIM.
| Gene symbol | Location | MIM number | Disorders |
|---|---|---|---|
| ALB | 4q13.3 | 103600 | Analbuminemia; dysalbuminemic hyperthyroxinemia |
| APOA5 | 11q23.3 | 606368 | Hypertriglyceridemia |
| BAX | 19q13.33 | 600040 | Colorectal cancer |
| BCL2 | 18q21.33 | 151430 | Leukemia/lymphoma |
| KDR | 4q12 | 191306 | Hemangioma, capillary infantile |
| MET | 7q31.2 | 164860 | Renal cell carcinoma |
| PGR | 11q22.1 | 607311 | Progesterone resistance |
| PHB | 17q21.33 | 176705 | Breast cancer |